Belvedere Trading LLC Immunovant, Inc. Call Options Transaction History

Belvedere Trading LLC

  • $77.2 Billion
  • Q1 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$31.31 - $44.19 $109,585 - $154,665
-3,500 Reduced 66.04%
1,800 $75,000
Q3 2023

Oct 27, 2023
BUY
$18.55 - $39.96 $98,315 - $211,788
5,300 New
5,300 $203,000
Q4 2021

Jan 25, 2022
SELL
$7.33 - $9.32 $60,106 - $76,424
-8,200 Closed
0 $0
Q3 2021

Oct 19, 2021
BUY
$7.01 - $11.37 $57,482 - $93,234
8,200 New
8,200 $70,000

Others Institutions Holding IMVT

# of Institutions
238
Shares Held
62.9M
Call Options Held
1.46M
Put Options Held
546K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email